mAb(J11); Mouse anti Human PAI1 Antibody; WB, IHC, IF, ICC; Unconjugated
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab120074-10μl | 10μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $69.90 | |
| Ab120074-20μl | 20μl | In stock | $99.90 | |
| Ab120074-50μl | 50μl | In stock | $199.90 | |
| Ab120074-100μl | 100μl | In stock | $299.90 | |
| Ab120074-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,299.90 |
mAb(J11); Mouse anti Human PAI1 Antibody; WB, IHC, IF, ICC; Unconjugated
| Product Name | PAI1 Mouse mAb - Primary antibody, specific to SERPINE1, Mouse IgG1 |
|---|---|
| Synonyms | Endothelial plasminogen activator inhibitor; Nexin; PAI1; PAI-1; PAI1PAI-1; PAISerpin E1; PLANH1; PLANH1plasminogen activator inhibitor 1; serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogenactivator inhibitor type 1), member 1; Serpin |
| Specifications & Purity | ExactAb™, Validated, Carrier Free, Azide Free, High performance, Lot by Lot |
| Host species | Mouse |
| Specificity | SERPINE1 |
| Immunogen | Recombinant PAI1 expressed in E.coli (AA 24-402). |
| Positive Control | WB: HeLa cell lysate. IHC: Human kidney tissue. IF/ICC: HeLa cells. |
| Conjugation | Unconjugated |
| Grade | Azide Free, Carrier Free, ExactAb™, High Performance, Validated |
| Product Description | Mouse anti Human PAI1 Antibody, Monoclonal(J11), could be used for WB, IHC, IF, ICC and so on . Application: WB: 0.01-2µg/mL IHC: 5-20µg/mL IF/ICC: 5-20µg/mL Protein Function This inhibitor acts as 'bait' for tissue plasminogen activator, urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis. |
| Isotype | Mouse IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 150 kDa |
| Purification Method | Protein A + Protein G purified |
| Form | Liquid |
| Concentration | Lot by Lot |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at 4℃ short term (1-2 weeks). Store at -20℃ long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
PAI1 Mouse mAb (Ab120074) - Western Blot
All lanes: PAI1 Mouse mAb (Ab120074) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Mouse IgG H&L (HRP) (Ab138040) at 1/20000 dilution
Predicted band size: 45 kDa
Observed band size: 47 kDa
Exposure time: 20.5 s
PAI1 Mouse mAb (Ab120074) - IF/ICC
FITC staining on IF
Sample: Human HeLa cells
Primary Ab: 20 μg/mL PAI1 Mouse mAb (Ab120074)
Second Ab: 5 μg/mL FITC-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.
PAI1 Mouse mAb (Ab120074) - IHC
DAB staining on IHC
Sample: Human Kidney Tissue
Primary Ab: 20 μg/mL PAI1 Mouse mAb (Ab120074)
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Application | Dilution info |
|---|---|
| IHC | 5-20 µg/mL |
| WB |
0.01-2 µg/mL
|
| IF/ICC | 5-20µg/mL |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ23F1201908 | Certificate of Analysis | Dec 06, 2023 | Ab120074 |
| ZJ23F1201907 | Certificate of Analysis | Dec 06, 2023 | Ab120074 |
| ZJ23F1201906 | Certificate of Analysis | Dec 06, 2023 | Ab120074 |
| 1. Elokdah H, Abou-Gharbia M, Hennan JK, McFarlane G, Mugford CP, Krishnamurthy G, Crandall DL.. (2004) Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization.. J Med Chem, 47 (14): (3491-3494). [PMID:15214776] |
| 2. Gorlatova NV, Cale JM, Elokdah H, Li D, Fan K, Warnock M, Crandall DL, Lawrence DA.. (2007) Mechanism of inactivation of plasminogen activator inhibitor-1 by a small molecule inhibitor.. J Biol Chem, 282 (12): (9288-9296). [PMID:17276980] |
| 3. El-Ayache NC, Li SH, Warnock M, Lawrence DA, Emal CD.. (2010) Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1).. Bioorg Med Chem Lett, 20 (3): (966-970). [PMID:20056540] |
| 4. Mottonen, J J and 7 more authors.. (1992) Structural basis of latency in plasminogen activator inhibitor-1.. Nature, (16): [PMID:1731226] |
| 5. Pannekoek, H H and 6 more authors.. (1986) Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.. The EMBO journal, [PMID:2430793] |
| 6. Follo, M M and Ginsburg, D D.. (1989) Structure and expression of the human gene encoding plasminogen activator inhibitor, PAI-1.. Gene, (14): [PMID:2612914] |
| 7. Andreasen, P A PA and 8 more authors.. (1986) Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.. FEBS letters, (15): [PMID:3025016] |
| 8. Wun, T C TC and Kretzmer, K K KK.. (1987) cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell.. FEBS letters, (1): [PMID:3026837] |
| 9. Ny, T T, Sawdey, M M, Lawrence, D D, Millan, J L JL and Loskutoff, D J DJ.. (1986) Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:3092219] |
| 10. Ginsburg, D D and 8 more authors.. (1986) cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.. The Journal of clinical investigation, [PMID:3097076] |
| 11. Bosma, P J PJ, van den Berg, E A EA, Kooistra, T T, Siemieniak, D R DR and Slightom, J L JL.. (1988) Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences.. The Journal of biological chemistry, (5): [PMID:3132455] |
| 12. Strandberg, L L, Lawrence, D D and Ny, T T.. (1988) The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family.. European journal of biochemistry, (1): [PMID:3262512] |
| 13. Sigurdardottir, O O and Wiman, B B.. (1994) Identification of a PAI-1 binding site in vitronectin.. Biochimica et biophysica acta, (21): [PMID:7522053] |
| 14. Aertgeerts, K K, De Bondt, H L HL, De Ranter, C J CJ and Declerck, P J PJ.. (1995) Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1.. Nature structural biology, [PMID:7552714] |
| 15. Lee, M H MH, Vosburgh, E E, Anderson, K K and McDonagh, J J.. (1993) Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.. Blood, (1): [PMID:8481516] |
| 16. Kjøller, L L and 8 more authors.. (1997) Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.. Experimental cell research, (1): [PMID:9168821] |
| 17. Türkmen, B B and 7 more authors.. (1997) Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer.. Electrophoresis, [PMID:9194591] |
| 18. Fay, W P WP, Parker, A C AC, Condrey, L R LR and Shapiro, A D AD.. (1997) Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene.. Blood, (1): [PMID:9207454] |
| 19. Xue, Y Y and 6 more authors.. (1998) Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.. Structure (London, England : 1993), (15): [PMID:9634700] |
| 20. Sharp, A M AM and 7 more authors.. (1999) The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.. Structure (London, England : 1993), (15): [PMID:10368279] |
| 21. Cargill, M M and 17 more authors.. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes.. Nature genetics, [PMID:10391209] |
| 22. and Sobel, B E BE.. (1999) Insulin resistance and thrombosis: a cardiologist's view.. The American journal of cardiology, (8): [PMID:10418858] |
| 23. Nar, H H and 5 more authors.. (2000) Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.. Journal of molecular biology, (31): [PMID:10731421] |
| 24. Nordt, T K TK, Peter, K K, Bode, C C and Sobel, B E BE.. (2000) Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells.. The Journal of clinical endocrinology and metabolism, [PMID:10770198] |
| 25. Kato, K K, Yamada, D D, Midorikawa, S S, Sato, W W and Watanabe, T T.. (2000) Improvement by the insulin-sensitizing agent, troglitazone, of abnormal fibrinolysis in type 2 diabetes mellitus.. Metabolism: clinical and experimental, [PMID:10831180] |
| 26. Kruszynska, Y T YT, Yu, J G JG, Olefsky, J M JM and Sobel, B E BE.. (2000) Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.. Diabetes, [PMID:10871202] |
| 27. Lindberg, P P, Kinnby, B B, Lecander, I I, Lang, N P NP and Matsson, L L.. (2001) Increasing expression of tissue plasminogen activator and plasminogen activator inhibitor type 2 in dog gingival tissues with progressive inflammation.. Archives of oral biology, [PMID:11163592] |
| 28. and Carr, M E ME.. () Diabetes mellitus: a hypercoagulable state.. Journal of diabetes and its complications, [PMID:11259926] |
| 29. Liu, C X CX, Li, Y Y, Obermoeller-McCormick, L M LM, Schwartz, A L AL and Bu, G G.. (2001) The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein.. The Journal of biological chemistry, (3): [PMID:11384978] |
| 30. and Idell, Steven.. (2002) Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.. Critical care medicine, [PMID:12004248] |
| 31. Gamberi, Gabriella G and 10 more authors.. () Identification of markers of possible prognostic value in 57 giant cell tumors of bone.. Oncology reports, [PMID:12579271] |
| 32. Shetty, Sreerama S, Bdeir, Khalil K, Cines, Douglas B DB and Idell, Steven S.. (2003) Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells.. The Journal of biological chemistry, (16): [PMID:12642587] |
| 33. and Hellgren, Margareta M.. (2003) Hemostasis during normal pregnancy and puerperium.. Seminars in thrombosis and hemostasis, [PMID:12709915] |
| 34. Chang, Hang H and 5 more authors.. () Cell adhesion induces the plasminogen activator inhibitor-1 gene expression through phosphatidylinositol 3-kinase/Akt activation in anchorage dependent cells.. Cell communication & adhesion, [PMID:12745435] |
| 35. Gerstein, E S ES, Shcherbakov, A M AM, Kaz'min, A I AI, Ognerubov, N A NA and Kushlinskiĭ, N E NE.. (2003) [Urokinase and tissue type plasminogen activators and their type-1 inhibitor (PAI-1) in gastric cancer].. Voprosy onkologii, [PMID:12785198] |
| 36. Hillier, Ladeana W LW and 106 more authors.. (2003) The DNA sequence of human chromosome 7.. Nature, (10): [PMID:12853948] |
| 37. Hattori, M M and Azami, Y Y.. (2001) Searching for preventive measures of cardiovascular events in aged Japanese taxi drivers--the daily rhythm of cardiovascular risk factors during a night duty day.. Journal of human ergology, [PMID:14564902] |
| 38. Degryse, Bernard B and 5 more authors.. (2004) The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1.. The Journal of biological chemistry, (21): [PMID:15001579] |
| 39. Szabo, Roman R, Netzel-Arnett, Sarah S, Hobson, John P JP, Antalis, Toni M TM and Bugge, Thomas H TH.. (2005) Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.. The Biochemical journal, (15): [PMID:15853774] |
| 40. Kortlever, Roderik M RM, Higgins, Paul J PJ and Bernards, René R.. (2006) Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.. Nature cell biology, [PMID:16862142] |
| 41. Cerchiara, E E, Tirindelli, M C MC, Giannetti, B B, Dicuonzo, G G and Avvisati, G G.. () [The numerous properties of the anticoagulant protein C].. La Clinica terapeutica, [PMID:17566522] |
| 42. Hilleman, Daniel E DE, Tsikouris, James P JP, Seals, A Allen AA and Marmur, Jonathan D JD.. (2007) Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.. Pharmacotherapy, [PMID:17963464] |
| 43. Providence, Kirwin M KM and 7 more authors.. (2008) SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repair.. Archives of dermatological research, [PMID:18386027] |
| 44. Thompson, Lawrence C LC, Goswami, Sumit S and Peterson, Cynthia B CB.. (2011) Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes.. Protein science : a publication of the Protein Society, [PMID:21280128] |
| 45. Rosenow, Anja A and 6 more authors.. (2012) Resveratrol-induced changes of the human adipocyte secretion profile.. Journal of proteome research, (7): [PMID:22905912] |
| 46. Jin, Hexiu H and 6 more authors.. (2015) Recombinant Human Plasminogen Activator Inhibitor-1 Promotes Cementogenic Differentiation of Human Periodontal Ligament Stem Cells.. Tissue engineering. Part A, [PMID:25808697] |
| 47. Jin, Bin B and Choung, Pill-Hoon PH.. (2016) Recombinant Human Plasminogen Activator Inhibitor-1 Accelerates Odontoblastic Differentiation of Human Stem Cells from Apical Papilla.. Tissue engineering. Part A, [PMID:27046084] |
| 48. Yao, Hui H and 10 more authors.. (2017) PAI1: a novel PP1-interacting protein that mediates human plasma's anti-apoptotic effect in endothelial cells.. Journal of cellular and molecular medicine, [PMID:28296156] |
| 49. Khan, Sadiya S SS and 13 more authors.. (2017) A null mutation in SERPINE1 protects against biological aging in humans.. Science advances, [PMID:29152572] |
| 50. Loskutoff, D J DJ and 5 more authors.. (1987) Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns.. Biochemistry, (30): [PMID:2820474] |
